We serve Chemical Name:6-aminocoumarin hydrochloride CAS:63989-79-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-aminocoumarin hydrochloride
CAS.NO:63989-79-7
Synonyms:6-Aminocoumarine Hydrochloride;6-amino-1,2-benzopyrone hydrochloride;6-AminocoumarinHcl;6-Abp;MFCD00082671;Coumarin,6-amino;6-Amino-cumarin,Hydrochlorid;6-Coumarinamine hydrochloride;6-amino-chromen-2-one hydrochloride;6-Aminocoumarin HCI;6-amino-coumarin,hydrochloride;6-amino-coumarihydrochloride
Molecular Formula:C9H8ClNO2
Molecular Weight:197.61800
HS Code:
Physical and Chemical Properties:
Melting point:>260°C (dec.)
Boiling point:396.9ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:56.23000
Exact Mass:197.02400
LogP:2.75840
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Aminocoumarine Hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-amino-coumarihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-amino-chromen-2-one hydrochloride Use and application,6-Aminocoumarine Hydrochloride technical grade,usp/ep/jp grade.
Related News: As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. 20α-(2-Piperidino-aethylamino)-3β-hydroxy-5α-pregnan manufacturers It is always advisable for companies to start the clinical study responsibilities early on to combat unforeseen challenges that require more time. 2α-Amino-3β-hydroxy-trans-decalin suppliers As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. 1H-Benzimidazole-6-carboxamide, 1-hydroxy-2-phenyl- vendor & factory The PLI scheme aims to accelerate indigenous manufacturing of critical bulk drugs for which India is dependent on imports. Under this scheme government offered incentives varying between 10 to 20%. ,The expansion will include six 1,000L small molecule reactors, four 1,500L vessels, and isolation equipment providing mid-scale capacity to bridge between early-phase and late-phase production.
